NCT02602197

Brief Summary

The investigators conducted a prospective, randomized, double blind study to compare the effectiveness of intravenous paracetamol and dexketoprofen for preventing pain during first 24 hours postoperative period in adult patient undergoing septoplasty.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2

participants targeted

Target at below P25 for phase_3 postoperative-pain

Timeline
Completed

Started Aug 2013

Longer than P75 for phase_3 postoperative-pain

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

March 31, 2015

Completed
8 months until next milestone

First Posted

Study publicly available on registry

November 11, 2015

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

November 11, 2015

Status Verified

November 1, 2015

Enrollment Period

2.3 years

First QC Date

March 31, 2015

Last Update Submit

November 10, 2015

Conditions

Keywords

ParacetamolDexketoprofenpostoperative painseptoplasty

Outcome Measures

Primary Outcomes (1)

  • Change from pain scores until postoperative 24 hours

    Pain scores as measured by Visual Analog Scale (VAS) at 15 and 30 minutes, 1h, 2h, 4h, 6h, 12h, and 24 h after surgery

    Pain scores recorded during postoperative 24 hours.

Secondary Outcomes (1)

  • Cumulative tramadol consumption during postoperative 24 hours.

    First postoperative 24 hours

Study Arms (2)

Paracetamol

ACTIVE COMPARATOR

1 gr paracetamol received intravenously bolus 15 minutes after anesthetic induction and at the postoperative 6 th,12 th, 18 th and 24 th hours

Drug: Paracetamol

Dexketoprofen

ACTIVE COMPARATOR

50 mg dexketoprofen received intravenous bolus 15 minutes after anesthetic induction and at the postoperative 8 th,16 th and 24 th hours.

Drug: Dexketoprofen

Interventions

After anesthetic induction, the first I.V bolus injections of 1 gr paracetamol (total amount of 100 ml) were given during 15 minutes and then repeated every 6 h until 24 h postoperative period.

Also known as: Parol
Paracetamol

After anesthetic induction, the first I.V bolus injections of 50 mg Dexketoprofen (premixed with 0.9 % sodium chloride to total amount of 100 ml) were given during 15 minutes and then repeated every 8 h until 24 h postoperative period.

Also known as: Arveles
Dexketoprofen

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • After patient's inform consent was approved, a total of 70 ASA (American Society of Anesthesiology) physical status I and II adult patients age 18 to 65 undergoing septoplasty were planned include the study.

You may not qualify if:

  • History of clotting disorders or blood dyscrasias,
  • Gastrointestinal ulcer or chronic dyspepsia,
  • History of allergy to the study drugs,
  • Active bleeding or bleeding disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Acetaminophendexketoprofen trometamol

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated Professor

Study Record Dates

First Submitted

March 31, 2015

First Posted

November 11, 2015

Study Start

August 1, 2013

Primary Completion

December 1, 2015

Study Completion

February 1, 2016

Last Updated

November 11, 2015

Record last verified: 2015-11